Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2010
10/20/2010EP2240200A2 Therapeutic myelin sheath derived antagonist peptide conjugates
10/20/2010EP2240167A1 Extruded rod-shaped devices for controlled release of biological substances to humans and animals
10/20/2010EP2240157A1 Ophthalmic preparations
10/20/2010EP2240152A1 Composition containing a retinoid and dispersed benzoyle peroxide
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010EP1581582B1 Thiol-selective water-soluble polmer derivatives
10/20/2010EP1519714B1 Method and apparatus for producing liposomes
10/20/2010CN1946429B Adhesive material
10/20/2010CN101868253A Preparations, methods and kits useful for treatment of cough
10/20/2010CN101868252A Preparations, methods and kits useful for treatment of cough
10/20/2010CN101868228A Orally disintegrating tablet
10/20/2010CN101868226A Composition for controlling lipase catalyzed reactions
10/20/2010CN101868223A Water-containing composition which can be used as external composition
10/20/2010CN101864178A Injected chemical crosslinking protein/polypeptide hydrogel and preparation method thereof
10/20/2010CN101864153A Biodegradable material and preparation method and application thereof
10/20/2010CN101864078A Polyethyleneimine-chitosan-octadecanoic acid grafting, preparation and application
10/20/2010CN101864075A Preparation method of gene vector material of glucocorticoid-modifying polyethyleneimine
10/20/2010CN101864071A Polyethylene glycol-distearoyl phosphatidyl ethanolamine derivant and preparation method thereof
10/20/2010CN101864069A Biodegradable hydrogel and synthesis method thereof
10/20/2010CN101864065A Biodegradable amphiphilic block copolymer containing cyclic ether side group and preparation method and applications thereof
10/20/2010CN101864019A Preparation method of sodium polystyrene sulfonate ion exchange resin
10/20/2010CN101863998A Modified saccharides, conjugates thereof, and their manufacture
10/20/2010CN101863985A Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer
10/20/2010CN101863827A N-ethyl-p-menthane-3-carboxamide derivative and preparation method thereof as well as application thereof as cooling agent
10/20/2010CN101863481A Amorphous silica particles having high absorbing capabilities and high structural characteristics
10/20/2010CN101862620A Emulsifier containing glycerine-modified organopolysiloxanes
10/20/2010CN101862458A Auxiliary material combination for improving atomizing and drying process of traditional Chinese medicine granules and application thereof
10/20/2010CN101862457A Degradable macromolecule carrier medicament as well as preparation method and application thereof
10/20/2010CN101862456A Remedy
10/20/2010CN101862455A In-situ gelling drug delivery system
10/20/2010CN101862454A Physical cross-linking hydrogel composition and preparation method and application thereof
10/20/2010CN101862453A New self emulsifying drug delivery system
10/20/2010CN101862452A Method for preparing swine multi-valent antiserum compound preparation
10/20/2010CN101862447A Natto kinase composition and preparation method thereof
10/20/2010CN101862445A Oral insulin containing protease inhibitor
10/20/2010CN101862441A Liniment containing natural Zingiber corallinum Hance essential oil with functions of analgesia, antiphlogosis, detumescence and itching-relieving
10/20/2010CN101862417A Natural spraying agent (dew) preventing and treating sneezing and snivel
10/20/2010CN101862363A General ginsenoside primary osmotic pump tablet and preparation method thereof
10/20/2010CN101862362A Hydroxypropyl-beta-cyclodextrin inclusion compound of ginseng essential oil, preparation method and application
10/20/2010CN101862347A Disinfectant
10/20/2010CN101862344A Mouthwash preparation containing nysfungin
10/20/2010CN101862326A Medicine compound containing febuxostat
10/20/2010CN101862325A Medicine compound containing candesartan cilexetil
10/20/2010CN101862321A Pharmaceutical composition with functions of hemangiectasis and beta 1 receptor retardation
10/20/2010CN101862311A Penetration promoting and eyesight improving eye drop
10/20/2010CN101862310A Transdermal system for varenicline
10/20/2010CN101862309A Glipizide sustained-release capsule and preparation method thereof
10/20/2010CN101862308A Aeromonas hydrophila micro-capsular oral vaccine
10/20/2010CN101862306A New type slightly soluble oral medicine self-emulsification preparation and preparation method thereof
10/20/2010CN101862305A Ambroxol hydrochloride sustained-release pellet and preparation method
10/20/2010CN101862303A Roxithromycin sustained release tablets and preparation method thereof
10/20/2010CN101862301A Tartraric rosiglitazone sustained release tablet and preparation method thereof
10/20/2010CN101862300A Lovastatin dispersible tablet and preparation method thereof
10/20/2010CN101862299A Preparation method of aspoxicillin freeze-dried powder injection
10/20/2010CN101862298A Benproperine phosphate granular formulation
10/20/2010CN101862297A Water-insoluble medicine sustained-release pellet, sustained-release orally disintegrating tablet thereof and preparation method thereof
10/20/2010CN101862295A Aggregate having enhanced deformability and including at least three amphipatic substances
10/20/2010CN101862293A Doxycycline hydrochloride oil turbid liquor, preparation method and application thereof
10/20/2010CN101862292A Ibuprofen suspension
10/20/2010CN101862291A Bone induction gel
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/20/2010CN101485736B Medicament composition with stone-eliminating and expelling functions and preparation method thereof
10/20/2010CN101342194B Traditional Chinese medicine preparation for treating median or late-stage malignant tumors, chronic hepatitis B, and preparation method thereof
10/20/2010CN101164530B Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof
10/20/2010CN101028524B Supersonic microvesicle target positioning controlled-release/gene device and target transferring method
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816409 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol
10/19/2010US7816373 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal
10/19/2010US7816341 Edible products, soft and hard capsules
10/19/2010US7816327 Topical administration for therapy of exposure to urushiol; irritating oils such as catechol-containing plant-derived antigens such as poison ivy, poison oak, poison sumac and Asian lacquer tree and oils containing capsaicin
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816318 emulsified nasal spray comprising macrocyclic permeation enhancer, liquid carrier comprising water, hydrocolloid emulsifying agent, and active agent other than insulin such as peptides, peptidomimetics, and proteins
10/19/2010US7816317 Tripeptide prodrug compounds
10/19/2010US7816316 hydrogel of hyaluronic acid derivative chemically crosslinked in solution in presence of pharmacologically active protein or peptide dissolved therein via dithiothreitol
10/19/2010US7815949 treating hot flashes in a post-menopausal female patient with the plant extracts; phytoestrogens for replace hormone replacement therapy; insomnia, vaginal dryness, decreased libido, and urinary incontinence; treating breast and/or uterine cancer, and osteoporosis
10/19/2010US7815938 Film coating
10/19/2010US7815937 Liquiflash particles and an excipient mass; friability of less than 1%; need for conventional super disintegrant and having a friability of less than 1%; no need for conventional superdisintegrant
10/19/2010US7815935 Orally distintegrating formulation and process for preparing the same
10/19/2010US7815933 Pre-concentrate emulsion of a nitrogen oxide-releasing NSAID, a surfactant, and an oil or fat, for oral administration; forming an oil-in-water emulsion with gastrointestinal fluids; side- effect reduction; bioavailability; treating pain and inflammation
10/19/2010US7815932 drug layer, support layer insoluble in water comprising ethyl cellulose and hydroxypropyl methylcellulose, backing on support layer, wherein drug layer consists of fentanyl or salt as active ingredient, methyl vinyl ether-maleic anhydride copolymer as adhesive, hydroxypropylcellulose; easily removed
10/19/2010US7815930 Food and feed supplement and its use
10/19/2010US7815922 Articles having bioactive surfaces and solvent-free methods of preparation thereof
10/19/2010US7815893 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/19/2010CA2565513C Pharmaceutical compositions comprising zd6474
10/19/2010CA2474634C Stable pharmaceutical composition useful for treating gastrointestinal disorders
10/19/2010CA2464491C Conditioning solution for contact lenses
10/19/2010CA2454006C Pullulan-containing powder, the process for the same and use thereof
10/19/2010CA2411590C Glycopeptide phosphonate derivatives
10/19/2010CA2379988C Enzyme catalyzed therapeutic activation
10/19/2010CA2286837C Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use
10/19/2010CA2241179C Dry compositions
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2147499C Prostate-specific membrane antigen
10/16/2010CA2700794A1 Emulsifier comprising glycerin-modified organopolysiloxanes
10/15/2010WO2009126950A2 Diterpene glycosides as natural solubilizers
10/15/2010CA2758122A1 Diterpene glycosides as natural solubilizers
10/14/2010WO2010118339A2 Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability
10/14/2010WO2010118142A1 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
10/14/2010WO2010117957A2 Methods and materials for delivering molecules
10/14/2010WO2010117287A2 A virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition.